CLINICAL RESEARCH |
|
Year : 2011 | Volume
: 32
| Issue : 1 | Page : 30-39 |
|
Clinical efficacy of Mehamudgara vati in type 2 diabetes mellitus
Ila Tanna1, HM Chandola2, JR Joshi3
1 Ph.D. Scholar, Department of Roga Nidana and Vikriti Vijnana, IPGT and RA, Gujarat Ayurved University, Jamnagar, India 2 Professor and Head, Department of Kayachikitsa, IPGT and RA, Gujarat Ayurved University, Jamnagar, India 3 Ex. Professor & HOD - Pathology, M. P. Shah Medical College, Jamnagar, Gujarat, India
Correspondence Address:
Ila Tanna Ph.D. Scholar, Department of Roga Nidana Evum Vikriti Vijnana, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, Gujarat India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0974-8520.85722
|
|
In type 2 diabetes, insulin resistance is the main problem that is associated with a cluster of conditions such as obesity and hyperlipidemia. The present study was designed with the objective to evaluate the role of Mehamudgara vati (MMV), which was expected to work at the level of Medodhatwagni due to its Medohara properties, to have an effective control on type 2 diabetes. To fulfill the objective, known patients of type 2 diabetes attending the OPD and IPD of Kayachikitsa Department, IPGT and RA, were selected and were divided in two groups. In Group A, MMV was given 3 tab. thrice a day with lukewarm water for 3 months and in Group B, the patients who were already taking modern antidiabetic treatment, although their blood sugar level was not well under control, were additionally given MMV in the same manner. The formulation has shown a highly significant decrease in the fasting and post-prandial blood sugar level. The formulation has also shown a synergistic action when combined with the modern antidiabetic drugs due to its known hypolipidemic, hypocholesterolemic, hepatoprotective, antihyperglycemic, antistress, antioxidant and immunomodulatory activities. |
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|